S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis.
about
New insights into the regulation of neutrophil NADPH oxidase activity in the phagosome: a focus on the role of lipid and Ca(2+) signalingCytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarminsMolecular interaction of a kinase inhibitor midostaurin with anticancer drug targets, S100A8 and EGFR: transcriptional profiling and molecular docking study for kidney cancer therapeuticsOncogenic Kras expression in postmitotic neurons leads to S100A8-S100A9 protein overexpression and gliosisIdentification of biomarkers for hepatocellular carcinoma using network-based bioinformatics methodsS100A9 is a biliary protein marker of disease activity in primary sclerosing cholangitis.Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection.Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature.S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis.Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches.An inflammation loop orchestrated by S100A9 and calprotectin is critical for development of arthritis.Zinc deficiency activates S100A8 inflammation in the absence of COX-2 and promotes murine oral-esophageal tumor progression.S100A8/A9 activate key genes and pathways in colon tumor progression.S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma.S100 proteins in cancer.Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice.Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100BS100A8 and S100A9: new insights into their roles in malignancy.Comprehensive Evaluation of Nuclear Factor-κΒ Expression Patterns in Non-Small Cell Lung Cancer.Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory Mediators.Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer.Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseasesAnalyses of Long Non-Coding RNA and mRNA profiling using RNA sequencing during the pre-implantation phases in pig endometrium.Robust shifts in S100a9 expression with aging: a novel mechanism for chronic inflammation.Proteomic analysis of the role of S-nitrosoglutathione reductase in lipopolysaccharide-challenged mice.Review of S100A9 biology and its role in cancer.Quantitative Proteomics Analysis of Tissue Interstitial Fluid for Identification of Novel Serum Candidate Diagnostic Marker for Hepatocellular Carcinoma.Functions of S100 proteins.Mechanism of interleukin-1α transcriptional regulation of S100A9 in a human epidermal keratinocyte cell line.S100 protein family in human cancer.Premetastatic milieu explained by TLR4 agonist-mediated homeostatic inflammation.New Concepts for Translational Head and Neck Oncology: Lessons from HPV-Related Oropharyngeal Squamous Cell CarcinomasNovel insights into the role of S100A8/A9 in skin biology.S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma.Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.Impact of S100A8/A9 expression on prostate cancer progression in vitro and in vivo.Micronutrient modulation of NF-κB in oral keratinocytes exposed to periodontal bacteria.Physiological regulation of transgene expression by a lentiviral vector containing the A2UCOE linked to a myeloid promoter.Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma
P2860
Q27004060-E79DD376-B197-4DBC-82E5-1EEDAB688788Q27021956-D9DF9752-04D9-4A3F-BD7D-E0CED48CE018Q28544659-05C31B5D-5A55-4686-99A5-B9885A62ACB8Q28589373-F982EF51-9F7D-40E2-8BED-4EA47206E10FQ33591504-0B175DBB-8260-4FD8-B16D-25D7DEDCF07BQ34130667-ABA83B4A-D2B6-4FDD-BB8A-82DD81DFABE6Q34190597-99FC59F0-568A-4DA3-9BFD-F872D0F6829CQ34241444-F71C3DAA-378D-4840-B18C-B257BE48C803Q34244767-D69888BC-0B96-438E-A477-E7AB555C474EQ34305848-3E62BBBE-223B-409C-A7B6-ECD925CB30EAQ34429165-A31AEA3E-5F59-4D41-A718-90CA5344DCE1Q34462187-BB8FD9EA-FB07-4CEA-A926-F2ED0AC353F2Q34802977-1AC617DF-1895-4568-9806-44499E245890Q34854105-DCAF7D84-FF29-4B86-B81B-BCBF5B4FB9EFQ35206368-EA51CC5E-EBB2-4181-927F-61B061930523Q35486021-C28E672B-66B8-43AE-89E9-FBCC7A1B4581Q35579991-37858E6F-9FB7-44E2-BD5A-9A371120203CQ35649454-3AF5D5B1-93B2-47FF-9094-240D18CBD682Q35683345-916E7ECD-D226-4BBF-9E12-F57F1404795BQ35931023-2EEB41C4-7DFD-41BD-BC97-56B295E05E5BQ35977804-532B03C6-8E38-450E-A385-900F5A7CC56AQ36299678-7568E5E5-5D42-4193-8AA4-8E84C6D00782Q36516965-263C7983-4E61-464D-B74E-A90CCD7F66E9Q36586653-55A1A395-7C28-447B-BE5B-BC4AAE70955EQ36682216-02FFF8D9-C364-445C-BFA4-F9AE04A40BEEQ36896567-72575A4D-667A-4EE5-B99E-65294587848CQ36928906-2D0CF101-56BE-4DA1-A4F0-BB105C1B7E16Q37001259-EC2D2D77-A011-4003-BFB7-10C36695771FQ37035475-FADA09C7-71EB-4BD9-A952-AD2437434914Q37650123-D5B4A4C1-1163-4B2C-A6E0-3DCFE4D49516Q37688889-FEDE4B83-F202-476F-9ED3-43246EC3A47BQ38015390-EFBCCA94-AFFA-483F-BD0F-6F630BBA935BQ38033682-A3359C82-EAAC-46FB-B21F-F7D771B6F377Q38061123-6C3A5349-9C24-4A19-9947-87DBBC3902F1Q38432576-19130F51-E2C1-4076-A643-F5352A46FB0FQ39079681-46A33B4B-5A51-4EF0-B49A-AFA70E086EADQ39297963-66459964-483D-454D-8079-F1CC7D798B75Q39445622-C92FDE67-6888-4CE0-ABC9-84E58DD73F4AQ39896275-3AB3D7E2-DC2B-43B8-BD34-DBC113D824FEQ39976770-766FFECE-16BD-4B64-8C1F-8734E65D2076
P2860
S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
S100A8 and S100A9 are novel nu ...... nd human liver carcinogenesis.
@en
S100A8 and S100A9 are novel nu ...... nd human liver carcinogenesis.
@nl
type
label
S100A8 and S100A9 are novel nu ...... nd human liver carcinogenesis.
@en
S100A8 and S100A9 are novel nu ...... nd human liver carcinogenesis.
@nl
prefLabel
S100A8 and S100A9 are novel nu ...... nd human liver carcinogenesis.
@en
S100A8 and S100A9 are novel nu ...... nd human liver carcinogenesis.
@nl
P2093
P2860
P356
P1433
P1476
S100A8 and S100A9 are novel nu ...... and human liver carcinogenesis
@en
P2093
Astrid Riehl
Daniel Haag
Elad Horwitz
Eli Pikarsky
Ilan Stein
Jochen Hess
Julia Németh
Meinhard Hahn
Peter Angel
Peter Schirmacher
P2860
P304
P356
10.1002/HEP.23099
P407
P577
2009-10-01T00:00:00Z